FDA includes stent grafts in tracking list

08/27/2008 | FDAnews

The FDA has included thoracic aortic aneurysm stent grafts in a list of medical devices that require monitoring, according to a final guidance issued last week. Class II or III devices may be subjected to the FDA's tracking requirements because of various factors, including risk of adverse health effects.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA